Synthetic Hormones Market Trends, Outlook And Industry Demand 2024-2033

The synthetic hormones global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

 

Synthetic Hormones Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

 

Market Size –

The synthetic hormones market size has grown strongly in recent years. It will grow from $6.0 billion in 2023 to $6.38 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%.  The growth in the historic period can be attributed to animal growth promotion, performance enhancement, environmental impact, fertility treatments and menopausal symptom management.

 

The synthetic hormones market size is expected to see strong growth in the next few years. It will grow to $7.79 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%.  The growth in the forecast period can be attributed to expansion of the transgender healthcare market, growing healthcare expenditure and insurance coverage, regulatory approvals, and expanding applications of synthetic hormones. Major trends in the forecast period include rise of plant-based hormone therapy, integration of hormone therapy in anti-aging treatments, technological advancements in drug delivery, and focus on hormone-free birth control.

 

Order your report now for swift delivery @

https://www.thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report

 

Scope Of Synthetic Hormones Market

The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

 

Synthetic Hormones Market Overview

Market Drivers –

The increasing incidence of hormonal imbalances is expected to propel the growth of the synthetic hormones market going forward. A hormonal imbalance refers to having too much or too little of a hormone in the blood, which can occur due to stress, aging, medical conditions, or lifestyle choices, disrupting the average production and regulation of hormones in the body. Synthetic hormones are used to supplement or replace natural hormones in hormonal imbalances, helping regulate bodily functions and alleviate symptoms associated with deficiencies or excesses. For instance, according to the NHS Business Services Authority, a UK-based non-departmental public body, in 2022, around 7.80 million hormone replacement therapy (HRT) items were prescribed in England, marking a 35.0% increase from the previous year. Therefore, the increasing incidence of hormonal imbalances is driving the growth of the synthetic hormones market.

 

Market Trends –

Major companies operating in the synthetic hormone market are focused on developing innovative products, such as recombinant human growth hormone, to increase their profitability in the market. Recombinant human growth hormone is a synthetic hormone used to treat growth hormone deficiency in children and adults, as well as certain medical conditions associated with growth hormone deficiency. For instance, in February 2022, Pfizer Inc., a US-based pharmaceutical company, and OPKO Health Inc., a US-based medical test and medication company, received marketing authorization for once-weekly NGENLA (somatrogon) injections in the European Union. These injections are intended to treat pediatric growth hormone deficiency in children and adolescents at least three years old. This new long-acting injection provides an alternative for individuals with growth disturbances caused by insufficient growth hormone secretion. NGENLA is administered subcutaneously and lasts longer in the body than daily growth hormone injections, making it possible to help it once a week.

 

The synthetic hormones market covered in this report is segmented –

1) By Product Type: Steroid Hormones, Peptide Hormone, Amino Acid Derivatives, Other Product Types

2) By Route of Administration: Oral, Nasal, Topical, Intravenous

3) By Application: Growth Hormone Deficiency, Thyroid Hormone Deficiency, Menopause, Male Hypogonadism, Other Applications

4) By End User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

 

Get an inside scoop of the synthetic hormones market, Request now for Sample Report @

https://www.thebusinessresearchcompany.com/sample.aspx?id=14514&type=smp

 

Regional Insights –

North America was the largest region in the synthetic hormones market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

 

Key Companies –

Major companies operating in the synthetic hormones market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol Myers Squibb Company, Sanofi SA, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Ferring B.V., Endo Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., IBSA Institute Biochimique SA, American Regent Inc., McGuff Pharmaceuticals Inc., Anhui Anke Biotechnology Co.Ltd., Lyndra Therapeutics Inc., Acerus Pharmaceuticals Corporation, Arch BioPartners Inc., Slayback Pharma LLC

 

Table of Contents

1. Executive Summary
2. Synthetic Hormones Market Characteristics
3. Synthetic Hormones Market Trends And Strategies
4. Synthetic Hormones Market – Macro Economic Scenario
5. Global Synthetic Hormones Market Size and Growth

………….

33. Global Synthetic Hormones Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Synthetic Hormones Market
35. Synthetic Hormones Market Future Outlook and Potential Analysis
36. Appendix

 

List Of Tables:

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Synthetic Hormones Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Synthetic Hormones Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Synthetic Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

………….

Table 75: Pfizer Inc. Financial Performance

Table 76: Johnson & Johnson Financial Performance

Table 77: AbbVie Inc. Financial Performance

Table 78: Bristol Myers Squibb Company Financial Performance

Table 79: Sanofi SA Financial Performance

 

Read Related Reports:

https://goodprnews.com/fluorescence-microscopy-market-strategies/

https://topprnews.com/high-speed-data-converter-market-future-outlook/

 

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

 

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model